Alessandro Giunta

Rome, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 72 publications

State of art and future challenges to early intervention, and management in patients with psoriasis at increased risk of transition to psoriatic arthritis: a review.

State of art and future challenges to early intervention, and management in patients with psoriasis at increased risk of transition to psoriatic arthritis: a review.

Journal: Expert review of clinical immunology

Published: January 09, 2026

Elective First-Line Use of Dimethyl Fumarate in Psoriasis: Insights from an Italian Cohort.

Elective First-Line Use of Dimethyl Fumarate in Psoriasis: Insights from an Italian Cohort.

Journal: Dermatology practical & conceptual

Published: June 25, 2025

Dermatologic Comorbidities Associated with Atopic Dermatitis Towards a Shared Therapeutical Approach: A Narrative Review.

Dermatologic Comorbidities Associated with Atopic Dermatitis Towards a Shared Therapeutical Approach: A Narrative Review.

Journal: Dermatology and therapy

Published: June 02, 2025

Intraclass switching of interleukin-23 inhibitors in psoriasis: effectiveness, patterns and predictors of response - a retrospective multicentre study in Italy.

Intraclass switching of interleukin-23 inhibitors in psoriasis: effectiveness, patterns and predictors of response - a retrospective multicentre study in Italy.

Journal: Clinical and experimental dermatology

Published: May 02, 2025

Super Responder Profile Under Bimekizumab Treatment in Moderate-to-Severe Psoriasis: A Short Term Real-Life Observation-IL PSO (Italian Landscape Psoriasis).

Super Responder Profile Under Bimekizumab Treatment in Moderate-to-Severe Psoriasis: A Short Term Real-Life Observation-IL PSO (Italian Landscape Psoriasis).

Journal: Clinical drug investigation

Published: April 08, 2025

Effectiveness of Bimekizumab in Psoriatic Arthritis: A Multicenter Real-Life Study With Clinical and Ultrasound Evaluation in the Lazio Region, Italy.

Effectiveness of Bimekizumab in Psoriatic Arthritis: A Multicenter Real-Life Study With Clinical and Ultrasound Evaluation in the Lazio Region, Italy.

Journal: International journal of dermatology

Published: March 18, 2025

Gender Influence on Bimekizumab Response in Patients with Psoriasis: Results of a Real-World Multicenter Retrospective Study-IL PSO (Italian Landscape PSOriasis).

Gender Influence on Bimekizumab Response in Patients with Psoriasis: Results of a Real-World Multicenter Retrospective Study-IL PSO (Italian Landscape PSOriasis).

Journal: Dermatology and therapy

Published: March 10, 2025

Effectiveness and Safety of Deucravacitinib in Moderate-to-Severe Psoriasis: an Italian Multicenter Real-Life Study in the Lazio Region.

Effectiveness and Safety of Deucravacitinib in Moderate-to-Severe Psoriasis: an Italian Multicenter Real-Life Study in the Lazio Region.

Journal: Dermatology practical & conceptual

Published: January 13, 2025

The risk of candidiasis during treatment with bimekizumab for the management of plaque psoriasis: a 16-week multicentre real-world experience - IL PSO (Italian Landscape Psoriasis).

The risk of candidiasis during treatment with bimekizumab for the management of plaque psoriasis: a 16-week multicentre real-world experience - IL PSO (Italian Landscape Psoriasis).

Journal: Clinical and experimental dermatology

Published: September 15, 2024

Fast Clinical Response of Bimekizumab in Nail Psoriasis: A Retrospective Multicenter 36-Week Real-Life Study.

Fast Clinical Response of Bimekizumab in Nail Psoriasis: A Retrospective Multicenter 36-Week Real-Life Study.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: August 22, 2024

Efficacy and Safety of bimekizumab in elderly patients: real-world multicenter retrospective study - IL PSO (Italian Landscape Psoriasis).

Efficacy and Safety of bimekizumab in elderly patients: real-world multicenter retrospective study - IL PSO (Italian Landscape Psoriasis).

Journal: The Journal of dermatological treatment

Published: August 20, 2024

Effectiveness of Ixekizumab in Elderly Patients for the Treatment of Moderate-to-Severe Psoriasis: Results From a Multicenter, Retrospective Real-Life Study in the Lazio Region.

Effectiveness of Ixekizumab in Elderly Patients for the Treatment of Moderate-to-Severe Psoriasis: Results From a Multicenter, Retrospective Real-Life Study in the Lazio Region.

Journal: Dermatology practical & conceptual

Published: March 14, 2024

Showing 1-12 of 72

Last Updated: 09/26/2026